$SLS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SELLAS Life Sciences Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SELLAS Life Sciences Group, Inc.. Get notifications about new insider transactions in SELLAS Life Sciences Group, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2021 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Option Exercise | A | 8.00 | 47,250 | 378,000 | 47,250 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 7,875 | 0 | 32,875 | 25 K to 32.9 K (+31.50 %) |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Option Exercise | A | 8.00 | 47,250 | 378,000 | 47,250 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 7,875 | 0 | 32,875 | 25 K to 32.9 K (+31.50 %) |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 8.00 | 7,500 | 60,000 | 7,500 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 8.00 | 7,500 | 60,000 | 7,500 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 8.00 | 7,500 | 60,000 | 7,500 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | Burns John Thomas | VP, Finance & Corp ... | Option Exercise | A | 8.00 | 17,250 | 138,000 | 17,250 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | Burns John Thomas | VP, Finance & Corp ... | Grant | A | 0.00 | 2,875 | 0 | 12,875 | 10 K to 12.9 K (+28.75 %) |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Option Exercise | A | 8.00 | 118,500 | 948,000 | 118,500 | |
Mar 08 2021 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Grant | A | 0.00 | 19,750 | 0 | 98,287 | 78.5 K to 98.3 K (+25.15 %) |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Option Exercise | A | 1.89 | 25,000 | 47,250 | 25,000 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Option Exercise | A | 1.89 | 70,000 | 132,300 | 70,000 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Grant | A | 0.00 | 95,000 | 0 | 95,000 | 0 to 95 K |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 1.89 | 6,500 | 12,285 | 6,500 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Burns John Thomas | VP, Finance & Corp ... | Option Exercise | A | 1.89 | 10,000 | 18,900 | 10,000 | |
Mar 16 2020 | SLS | SELLAS Life Scienc ... | Burns John Thomas | VP, Finance & Corp ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Sarlis Nicholas J. | Chief Medical Offic ... | Option Exercise | A | 1.38 | 50,000 | 69,000 | 50,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Ghiglieri Stephen F | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Burns John Thomas | VP, Finance & Corp ... | Option Exercise | A | 1.38 | 90,000 | 124,200 | 90,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Option Exercise | A | 1.38 | 425,000 | 586,500 | 425,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 1.38 | 25,000 | 34,500 | 25,000 | |
Mar 18 2019 | SLS | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Option Exercise | A | 1.38 | 165,000 | 227,700 | 165,000 | |
Jan 03 2019 | SLS | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Sell | S | 1.25 | 23,277 | 29,189 | 426,858 | 450.1 K to 426.9 K (-5.17 %) |
Sep 26 2018 | SLS | SELLAS Life Scienc ... | Lopez Fabio | Sell | J | 0.00 | 325,799 | 0 | 0 | 325.8 K to 0 (-100.00 %) | |
Sep 26 2018 | SLS | SELLAS Life Scienc ... | Lopez Fabio | Sell | J | 0.00 | 676,324 | 0 | 0 | 676.3 K to 0 (-100.00 %) | |
Sep 26 2018 | SLS | SELLAS Life Scienc ... | Lopez Fabio | Sell | J | 0.00 | 1,521,863 | 0 | 0 | 1.5 M to 0 (-100.00 %) | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | Ghiglieri Stephen F | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Jun 13 2018 | SLS | SELLAS Life Scienc ... | Lopez Fabio | Director | Option Exercise | A | 5.23 | 5,500 | 28,765 | 5,500 | |
Apr 24 2018 | SLS | SELLAS Life Scienc ... | Mack Gene | CFO and Treasurer | Option Exercise | A | 5.38 | 40,000 | 215,200 | 40,000 | |
Mar 16 2018 | GALE | SELLAS Life Scienc ... | WOOD BARBARA A | EVP, Gen. Counsel, ... | Option Exercise | A | 5.10 | 50,000 | 255,000 | 50,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Wasman Jane | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Varian John | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Ghiglieri Stephen F | Director | Option Exercise | A | 5.24 | 11,000 | 57,640 | 11,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Torre Gregory M | CRO and SVP | Option Exercise | A | 5.24 | 30,000 | 157,200 | 30,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Sarlis Nicholas J. | Chief Medical Offic ... | Option Exercise | A | 5.24 | 70,000 | 366,800 | 70,000 | |
Mar 15 2018 | GALE | SELLAS Life Scienc ... | Stergiou Angelos M. | President and CEO | Option Exercise | A | 5.24 | 95,000 | 497,800 | 95,000 | |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Stergiou Andelos M. | President and CEO | Grant | A | 0.00 | 450,135 | 0 | 450,135 | 0 to 450.1 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | SCHEINBERG DAVID A | Director | Grant | A | 0.00 | 9,107 | 0 | 9,107 | 0 to 9.1 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Option Exercise | A | 0.00 | 316,163 | 0 | 316,163 | |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 3,343 | 0 | 3,343 | 0 to 3.3 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 3,343 | 0 | 3,343 | 0 to 3.3 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 58,208 | 0 | 58,208 | 0 to 58.2 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 325,799 | 0 | 325,799 | 0 to 325.8 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 676,324 | 0 | 676,324 | 0 to 676.3 K |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 1,521,863 | 0 | 1,521,863 | 0 to 1.5 M |
Dec 29 2017 | GALE | SELLAS Life Scienc ... | Lopez Fabio | Director | Grant | A | 0.00 | 149,766 | 0 | 149,766 | 0 to 149.8 K |
Oct 10 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Grant | A | 0.38 | 17,130 | 6,509 | 42,918 | 25.8 K to 42.9 K (+66.43 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.38 | 15,472 | 5,879 | 39,167 | 23.7 K to 39.2 K (+65.30 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.38 | 20,997 | 7,979 | 56,950 | 36 K to 57 K (+58.40 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Grant | A | 0.38 | 13,814 | 5,249 | 36,039 | 22.2 K to 36 K (+62.16 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Grant | A | 0.38 | 14,366 | 5,459 | 34,690 | 20.3 K to 34.7 K (+70.68 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.38 | 15,472 | 5,879 | 38,154 | 22.7 K to 38.2 K (+68.21 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.38 | 12,708 | 4,829 | 31,339 | 18.6 K to 31.3 K (+68.21 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Grant | A | 0.59 | 9,161 | 5,405 | 20,114 | 11 K to 20.1 K (+83.64 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.59 | 9,866 | 5,821 | 22,682 | 12.8 K to 22.7 K (+76.98 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Grant | A | 0.59 | 8,809 | 5,197 | 22,225 | 13.4 K to 22.2 K (+65.66 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.59 | 13,390 | 7,900 | 35,953 | 22.6 K to 36 K (+59.34 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.59 | 8,104 | 4,781 | 18,631 | 10.5 K to 18.6 K (+76.98 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 9,866 | 5,821 | 23,695 | 13.8 K to 23.7 K (+71.34 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Grant | A | 0.59 | 10,924 | 6,445 | 25,788 | 14.9 K to 25.8 K (+73.49 %) |
Jun 22 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Sell | S | 0.55 | 500 | 273 | 14,864 | 15.4 K to 14.9 K (-3.25 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Grant | A | 0.59 | 10,927 | 6,447 | 15,364 | 4.4 K to 15.4 K (+246.27 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 0.59 | 8,815 | 5,201 | 13,829 | 5 K to 13.8 K (+175.81 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.59 | 13,394 | 7,902 | 22,563 | 9.2 K to 22.6 K (+146.08 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Grant | A | 0.59 | 9,865 | 5,820 | 13,416 | 3.6 K to 13.4 K (+277.81 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Grant | A | 0.59 | 8,638 | 5,096 | 10,953 | 2.3 K to 11 K (+373.13 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.59 | 8,107 | 4,783 | 10,527 | 2.4 K to 10.5 K (+335.00 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 0.59 | 9,870 | 5,823 | 12,816 | 2.9 K to 12.8 K (+335.03 %) |
Feb 10 2017 | GALE | Galena Biopharma, ... | Hudson Bay Capital Management ... | 10% Owner | Option Exercise | P | 1.00 | 1,100 | 1,100 | 0 | |
Feb 10 2017 | GALE | Galena Biopharma, ... | Hudson Bay Capital Management ... | 10% Owner | Sell | S | 0.84 | 2,363,441 | 1,985,290 | 2,036,559 | 4.4 M to 2 M (-53.71 %) |
Feb 07 2017 | GALE | Galena Biopharma, ... | Knapp Thomas J | General Counsel | Option Exercise | A | 1.41 | 10,000 | 14,100 | 10,000 | |
Jan 24 2017 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Grant | A | 1.98 | 2,525 | 5,000 | 5,004 | 2.5 K to 5 K (+101.86 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Ashton William | Director | Grant | A | 1.98 | 2,946 | 5,833 | 2,946 | 0 to 2.9 K |
Jan 24 2017 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 1.98 | 3,998 | 7,916 | 9,169 | 5.2 K to 9.2 K (+77.32 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Grant | A | 1.98 | 3,262 | 6,459 | 4,437 | 1.2 K to 4.4 K (+277.62 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 1.98 | 2,420 | 4,792 | 2,420 | 0 to 2.4 K |
Jan 24 2017 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Grant | A | 1.98 | 3,051 | 6,041 | 3,551 | 500 to 3.6 K (+610.20 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Grant | A | 1.98 | 2,525 | 5,000 | 2,525 | 0 to 2.5 K |
Jan 19 2017 | GALE | Galena Biopharma, ... | Nejadnik Bijan | Chief Medical Offic ... | Option Exercise | A | 1.81 | 30,000 | 54,300 | 30,000 | |
Jan 19 2017 | GALE | Galena Biopharma, ... | Knapp Thomas J | General Counsel | Option Exercise | A | 1.81 | 5,000 | 9,050 | 5,000 | |
Jan 19 2017 | GALE | Galena Biopharma, ... | Burns John Thomas | Vice President, Fin ... | Option Exercise | A | 1.81 | 15,000 | 27,150 | 15,000 | |
Dec 20 2016 | GALE | Galena Biopharma, ... | Knapp Thomas J | General Counsel | Option Exercise | A | 0.29 | 102,000 | 29,580 | 102,000 | |
Nov 15 2016 | GALE | Galena Biopharma, ... | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 0.19 | 1,000,000 | 190,000 | 1,000,000 | |
Jul 20 2016 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 18 2016 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jul 08 2016 | GALE | Galena Biopharma, ... | Nejadnik Bijan | Chief Medical Offic ... | Buy | J | 0.40 | 8,503 | 3,397 | 8,503 | 0 to 8.5 K |
Jul 06 2016 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | President & CEO | Buy | J | 0.40 | 8,503 | 3,397 | 439,978 | 431.5 K to 440 K (+1.97 %) |
Jul 06 2016 | GALE | Galena Biopharma, ... | Burns John Thomas | Principal Accountin ... | Buy | J | 0.40 | 8,503 | 3,397 | 10,899 | 2.4 K to 10.9 K (+354.88 %) |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Option Exercise | M | 1.71 | 30,000 | 51,300 | 0 | |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Option Exercise | M | 1.85 | 65,625 | 121,406 | 30,000 | |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Option Exercise | M | 1.75 | 31,250 | 54,688 | 95,625 | |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Sell | S | 2.18 | 126,875 | 276,588 | 18,702 | 145.6 K to 18.7 K (-87.15 %) |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Buy | M | 1.71 | 30,000 | 51,300 | 145,577 | 115.6 K to 145.6 K (+25.96 %) |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Buy | M | 1.85 | 65,625 | 121,406 | 115,577 | 50 K to 115.6 K (+131.38 %) |
Jun 07 2016 | GALE | Galena Biopharma, ... | Dunlap Ryan | Former Chief Financ ... | Buy | M | 1.75 | 31,250 | 54,688 | 49,952 | 18.7 K to 50 K (+167.09 %) |
Apr 28 2016 | GALE | Galena Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 1.40 | 200,000 | 280,000 | 200,000 | |
Mar 04 2016 | GALE | Galena Biopharma, ... | Burns John Thomas | Principal Accountin ... | Option Exercise | A | 0.84 | 75,000 | 63,000 | 75,000 | |
Dec 29 2015 | GALE | Galena Biopharma, ... | Nejadnik Bijan | Executive VP and CM ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Dec 29 2015 | GALE | Galena Biopharma, ... | Nejadnik Bijan | Executive VP and CM ... | Option Exercise | A | 1.68 | 350,000 | 588,000 | 350,000 | |
Dec 22 2015 | GALE | Galena Biopharma, ... | Knapp Thomas J | General Counsel | Option Exercise | A | 1.50 | 225,000 | 337,500 | 225,000 | |
Dec 22 2015 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | President and CEO | Option Exercise | A | 1.50 | 1,250,000 | 1,875,000 | 1,250,000 | |
Jul 16 2015 | GALE | Galena Biopharma, ... | Knapp Thomas J | General Counsel | Option Exercise | A | 1.83 | 40,000 | 73,200 | 40,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Ashton William | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Jan 20 2015 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | President & CEO | Option Exercise | A | 1.75 | 550,000 | 962,500 | 550,000 | |
Jan 20 2015 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | President & CEO | Buy | J | 1.28 | 3,846 | 4,923 | 415,972 | 412.1 K to 416 K (+0.93 %) |
Jan 20 2015 | GALE | Galena Biopharma, ... | Dunlap Ryan | VP, Chief Financial ... | Option Exercise | A | 1.75 | 125,000 | 218,750 | 125,000 | |
Jan 20 2015 | GALE | Galena Biopharma, ... | Dunlap Ryan | VP, Chief Financial ... | Buy | J | 1.28 | 3,846 | 4,923 | 11,650 | 7.8 K to 11.7 K (+49.28 %) |
Jan 20 2015 | GALE | Galena Biopharma, ... | Kivinski Margaret | VP and General Coun ... | Option Exercise | A | 1.75 | 50,000 | 87,500 | 50,000 | |
Sep 18 2014 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | President & CEO | Option Exercise | A | 2.23 | 200,000 | 446,000 | 200,000 | |
Jul 29 2014 | GALE | Galena Biopharma, ... | Kivinski Margaret | VP and General Coun ... | Option Exercise | A | 2.92 | 200,000 | 584,000 | 200,000 | |
Jul 02 2014 | GALE | Galena Biopharma, ... | SCHWARTZ MARK W. | EVP, Chief Operatin ... | Buy | J | 2.60 | 2,461 | 6,399 | 412,126 | 409.7 K to 412.1 K (+0.60 %) |
Jul 02 2014 | GALE | Galena Biopharma, ... | HAMILTON BRIAN L | EVP, Chief Medical ... | Buy | J | 2.60 | 2,461 | 6,399 | 2,461 | 0 to 2.5 K |
Jul 02 2014 | GALE | Galena Biopharma, ... | Dunlap Ryan | VP, Chief Financial ... | Buy | J | 2.60 | 2,461 | 6,399 | 7,804 | 5.3 K to 7.8 K (+46.06 %) |
Jul 02 2014 | GALE | Galena Biopharma, ... | Ahn Mark J | President & CEO | Buy | J | 2.60 | 2,461 | 6,399 | 116,225 | 113.8 K to 116.2 K (+2.16 %) |
Apr 21 2014 | GALE | Galena Biopharma, ... | Einhorn Irving M. | Director | Option Exercise | A | 1.80 | 100,000 | 180,000 | 100,000 | |
Apr 09 2014 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Option Exercise | M | 2.31 | 50,000 | 115,500 | 0 | |
Apr 09 2014 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Option Exercise | M | 1.18 | 100,000 | 118,000 | 0 |